Barbara G. Utterback

2.3k citations

21 papers · 1.5k indexed · 1 hit paper · h-index 13

Impact in

Critical Care and Intensive Care Medicine top 1%
- Trauma, Hemostasis, Coagulopathy, Resuscitation
- Nosocomial Infections in ICU
Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management

Papers in ⓘ

Critical Care and Intensive Care Medicine 3
Hematology 5
- Platelet Disorders and Treatments 3

Co-authors: Pierre‐François Laterre (3 shared papers)S. Betty Yan (2 shared papers)Howard Levy (3 shared papers)Edward Abraham (2 shared papers)William L. Macias (2 shared papers)Bruce R. Basson (2 shared papers)Rolf Rossaint (1 shared paper)Bruno François (1 shared paper)
Journals: Journal of Medicinal Chemistry (4 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Critical Care Medicine (2 papers)Expert Opinion on Drug Safety (1 paper)International Journal of Infectious Diseases (1 paper)
Partner nations: United States France Belgium

In The Last Decade

Barbara G. Utterback

21 papers receiving 1.5k citations

Hit Papers

align trajectories log scale

Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death 2005 · 567 citations

Peers

Countries citing papers authored by Barbara G. Utterback

Since Specialization

Citations

This map shows the geographic impact of Barbara G. Utterback's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara G. Utterback with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara G. Utterback more than expected).

Fields of papers citing papers by Barbara G. Utterback

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara G. Utterback. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara G. Utterback. The network helps show where Barbara G. Utterback may publish in the future.

Co-authors

The 25 scholars most cited alongside Barbara G. Utterback, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Barbara G. Utterback Line = papers co-authored together Barbara G. Utterback links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death New England Journal of Medicine ·Edward Abraham, Pierre‐François Laterre, Rekha Garg, Howard Levy, Deepak Talwar, Benjamin Trzaskoma, Bruno François, Jeffrey S. Guy, Martina Brückmann, Álvaro Réa-Neto, Rolf Rossaint, D. Perrotin, Armin Sablotzki, Nancy Arkins, Barbara G. Utterback, William L. Macias Hit paper breakdown →	2005	567
2	Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569] Critical Care ·Gary T. Kinasewitz, S. Betty Yan, Bruce R. Basson, Philip C. Comp, James A. Russell, Alain Cariou, Suzane L. Um, Barbara G. Utterback, Pierre-François Laterre, Jean-François Dhainaut, (unknown)	2004	291
3	Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications Critical Care Medicine ·Rolf M. Mesters, Jeff Helterbrand, Barbara G. Utterback, S. Betty Yan, Ye Chao, José A. Fernández, John H. Griffin, Daniel Hartman	2000	158
4	Differential Activation of Cytosolic Phospholipase A2 (cPLA2) by Thrombin and Thrombin Receptor Agonist Peptide in Human Platelets. EVIDENCE FOR ACTIVATION OF cPLA2 INDEPENDENT OF THE MITOGEN-ACTIVATED PROTEIN KINASES ERK1/2 Journal of Biological Chemistry ·Ruth M. Kramer, Edda F. Roberts, Paul A. Hyslop, Barbara G. Utterback, Kwan Y. Hui, Joseph A. Jakubowski	1995	114
5	Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trial Intensive Care Medicine ·Jean-François Dhainaut, Pierre‐François Laterre, Jonathan Janes, Gordon R. Bernard, Antonio Artigas, Jan Bakker, Hanno Riess, Bruce R. Basson, Julien Charpentier, Barbara G. Utterback, Jean‐Louis Vincent, (unknown)	2003	109
6	The clinical evaluation committee in a large multicenter phase 3 trial of drotrecogin alfa (activated) in patients with severe sepsis (PROWESS): Role, methodology, and results* Critical Care Medicine ·Jean-François Dhainaut, Pierre-François Laterre, Steven P. LaRosa, Howard Levy, Gary Garber, Darell Heiselman, Gary T. Kinasewitz, R. Bruce Light, Peter E. Morris, Roland M.H. Schein, Jean-Pierre Sollet, Becky Bates, Barbara G. Utterback, Dennis G. Maki	2003	69
7	ENHANCE: Results of a global open-label trial of drotrecogin alfa (activated) in children with severe sepsis* Pediatric Critical Care Medicine ·Brahm Goldstein, Simon Nadel, Mark Peters, Roger Barton, Flávia Ribeiro Machado, Howard Levy, Douglas J. Haney, Barbara G. Utterback, Mark D. Williams, Brett P. Giroir	2006	38
8	Non-Peptide RGD Surrogates Which Mimic a Gly-Asp β-Turn: Potent Antagonists of Platelet Glycoprotein IIb−IIIa Journal of Medicinal Chemistry ·Matthew J. Fisher, Bruce P. Gunn, Cathy S. Harms, Allen D. Kline, Jeffrey T. Mullaney, Anne Nunes, Robert M. Scarborough, Ann Arfsten, Marshall A. Skelton, Suzane L. Um, Barbara G. Utterback, Joseph A. Jakubowski	1997	37
9	Decreased protein C, protein S, and antithrombin levels are predictive of poor outcome in Gram-negative sepsis caused by Burkholderia pseudomallei International Journal of Infectious Diseases ·Steven P. LaRosa, Steven M. Opal, Barbara G. Utterback, Sau Chi Betty Yan, Jeffrey D. Helterbrand, Andrew J. H. Simpson, Wipada Chaowagul, Nicholas J. White, Charles J. Fisher	2005	34
10	Safety and tolerability of duloxetine in the acute management of diabetic peripheral neuropathic pain: analysis of pooled data from three placebo-controlled clinical trials Expert Opinion on Drug Safety ·Jerry Hall, Fujun Wang, Tina M. Oakes, Barbara G. Utterback, Antonio Crucitti, Nayan Acharya	2010	20
11	Synthesis of a tritium-labeled indolidan analog and its use as a radioligand for phosphodiesterase-inhibitor cardiotonic binding sites Journal of Medicinal Chemistry ·David W. Robertson, Joseph H. Krushinski, Barbara G. Utterback, Raymond F. Kauffman	1989	15
12	International integrated database for the evaluation of severe sepsis and drotrecogin alfa (activated) therapy: 28-day survival and safety Journal of Critical Care ·Pierre‐François Laterre, David R. Nelson, William L. Macias, Edward Abraham, Andreas Sashegyi, Mark D. Williams, Mitchell M. Levy, Marcel Levi, Barbara G. Utterback, Jean‐Louis Vincent	2007	15
13	Use of Conformationally Restricted Benzamidines as Arginine Surrogates in the Design of Platelet GPIIb-IIIa Receptor Antagonists Journal of Medicinal Chemistry ·Daniel J. Sall, Ann Arfsten, Jolie Bastian, Michael L. Denney, Cathy S. Harms, Jefferson R. McCowan, J. M. JUN. MORIN, Jack W. Rose, Robert M. Scarborough, Mark S. Smyth, Suzane L. Um, Barbara G. Utterback, Robert T. Vasileff, James H. Wikel, Virginia L. Wyss, Joseph A. Jakubowski	1997	15
14	Development of Dual-Acting Agents for Thromboxane Receptor Antagonism and Thromboxane Synthase Inhibition. 3. Synthesis and Biological Activities of Oxazolecarboxamide-Substituted ω-Phenyl-ω-(3-pyridyl)alkenoic Acid Derivatives and Related Compounds Journal of Medicinal Chemistry ·Kumiko Takeuchi, Todd J. Kohn, Timothy A. True, Dale E. Mais, James H. Wikel, Barbara G. Utterback, Virginia L. Wyss, Joseph A. Jakubowski	1998	10
15	Cardiac inotropic responses to calcium and forskolin are not altered by prolonged isoproterenol infusion European Journal of Pharmacology ·Nancy Bowling, Virginia L. Wyss, Peter J. Gengo, Barbara G. Utterback, Raymond F. Kauffman, J S Hayes	1990	8
16	Dihydroisoquinolone RGD mimics. Exploration of the aspartate isostere Bioorganic & Medicinal Chemistry Letters ·Matthew J. Fisher, Bruce P. Gunn, Cathy S. Harms, Allen D. Kline, Jeffrey T. Mullaney, Robert M. Scarborough, Marshall A. Skelton, Suzane L. Um, Barbara G. Utterback, Joseph A. Jakubowski	1997	8
17	LY249933 Journal of Cardiovascular Pharmacology ·Donald R. Holland, James H. Wikel, Raymond F. Kauffman, Jeffrey K. Smallwood, Karen M. Zimmerman, Barbara G. Utterback, John A. Turk, Mitchell I. Steinberg	1989	7
18	Development of dual-acting agents for thromboxane receptor antagonism and thromboxane synthase inhibition-I. Synthesis, structure-activity relationship, and evaluation of substituted (ω-phenyl-ω)-(3-pyridyl)alkenoic acids Bioorganic & Medicinal Chemistry ·Kumiko Takeuchi, Anne M. Happ, Dale E. Mais, Nicki Layman, Barbara G. Utterback, Virginia L. Wyss, Joseph A. Jakubowski	1994	6
19	Biochemical and pharmacological activity of arene-fused prostacyclin analogues on human platelets Prostaglandins ·Joseph A. Jakubowski, Barbara G. Utterback, Dale E. Mais, Stephen A. Hardinger, T. F. BRAISH, C. Richard Nevill, P. L. Fuchs	1994	5
20	Platelet glycoprotein IIb–IIIa receptor (GPIIb–IIIa) antagonists derived from amidinoindoles Bioorganic & Medicinal Chemistry Letters ·Daniel J. Sall, Ann Arfsten, Dennis R. Berry, Michael L. Denney, Cathy S. Harms, Jefferson R. McCowan, Judith K. Ray, Robert M. Scarborough, Suzane L. Um, Barbara G. Utterback, Joseph A. Jakubowski	1996	4

About Barbara G. Utterback

Barbara G. Utterback is a scholar working on Critical Care and Intensive Care Medicine, Hematology, Cardiology and Cardiovascular Medicine, Pharmacology and Epidemiology, having authored 21 papers that have together received 1.5k indexed citations. Recurring topics across this work include Sepsis Diagnosis and Treatment (7 papers), Inflammatory mediators and NSAID effects (4 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (3 papers), Receptor Mechanisms and Signaling (3 papers), Chemical Synthesis and Analysis (3 papers), Platelet Disorders and Treatments (3 papers), Synthesis and Reactivity of Sulfur-Containing Compounds (2 papers) and Antiplatelet Therapy and Cardiovascular Diseases (2 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (334 citations), Internal Medicine (106 citations), Hematology (311 citations), Epidemiology (937 citations) and Family Practice (53 citations). Barbara G. Utterback has collaborated with scholars based in United States, France and Belgium. Frequent co-authors include Pierre‐François Laterre, S. Betty Yan, Howard Levy, Edward Abraham, William L. Macias, Bruce R. Basson, Rolf Rossaint, Bruno François, Deepak Talwar and Benjamin Trzaskoma. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Critical Care Medicine, Expert Opinion on Drug Safety and International Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact